Date of filling in this questionnaire or last update: 28/04/2021
1. IDENTIFICATION & BASIC DESCRIPTION
Cohort name
  The Cement Australia Railton Study
Country
 

  • Australia

Name
  Prof Malcolm Sim
Institution
  Monash University
Email
  malcolm.sim@monash.edu
Personal website
  https://research.monash.edu/en/persons/malcolm-sim
Do you want to add another Principal Investigator of the Cohort
 

  • Add another Principal Investigator of the cohort

Name
  Dr Geza Benke
Institution
  Monash University
Email
  Geza.Benke@monash.edu
Personal website
  https://research.monash.edu/en/persons/geza-benke
Do you want to add another Principal Investigator of the Cohort
 

  • Add another Principal Investigator of the cohort

Name
  Dr Ewan MacFarlane
Institution
  Monash University
Email
  Ewan.MacFarlane@monash.edu
Personal website
  https://research.monash.edu/en/persons/ewan-macfarlane
Website
 

  • https://www.monash.edu/medicine/sphpm/coeh/research/cement-australia-railton-study

Name of committee
  Monash University Human Research Ethics Committee
Or provide website
 

  • https://www.monash.edu/medicine/sphpm/coeh/research/cement-australia-railton-study

Contact Principal Investigator (name)
  Malcolm Sim
Main aim of cohort, please briefly describe the main objectives of the cohort
  Investigation into cancer and mortality at the Cement Australia Railton facility in Tasmania.
Study design (please select as many as appropriate)
 

  • Prospective cohort

Source population (please select as many as appropriate)
 

  • Industry / occupation-based

Comparators (please select as many as appropriate)
 

  • External study population (includes SMR/SIR studies)

Inclusion criteria
  Current or former workers from cement manufacturing plant in Tasmania
Exclusion criteria
  Only current employees were given the option of opting out of the study, the rest of the cohort was automatically included, but never contacted.
Enrollment
  Ongoing
Age range at entry (main cohort)
 

Minimum Maximum Mean
18

Age range at entry (subcohort)
 

Minimum Maximum Mean Please describe
>18

2. OUTCOME FOLLOW-UP
Type of data for outcome follow-up (please select as many as appropriate)
 

  • Death certificate

Death certificate (specify)
 

  • Data linkage with the National Death Index. Five- to ten-year intervals, funding dependent.

First follow-up period (provide year)
  2010-2011
Number of follow-ups after baseline (provide number)
  1
3. OCCUPATIONAL EXPOSURES
Source of exposure data collected (please select as many as appropriate)
 

  • Questionnaire, Personal (Self-reporting or interview)
  • Questionnaire, Personal (Occupational/industry modules)
  • Job-employment records

Occupational history/time frame
  Lifetime
Occupational coding performed
  No
Methods for exposure assessment (please select as many as appropriate)
 

  • Expert assessment

Main categories
 

  • Other (specify)

Main categories | Other | Specify: Other
  Asbestos
Comments
  This cohort study tracks cancer and mortality of current and former workers at a cement manufacturing plant which previously produced asbestos-cement products in Railton, Tasmania. Although the use of asbestos was phased out at Railton in the 1980s, risk of health effects among this workforce may still remain because asbestos-related diseases may not emerge until many years after exposure.
4. OUTCOMES EVALUATED
Baseline - type of outcome data collected (select more than one if applicable)
 

  • Death certificates
  • Questionnaire, individual (self-recording or interview)

Follow-up - type of outcome data collected (select more than one if applicable)
 

  • Death certificates

Outcome type (please select as many as appropriate)
 

  • Mortality
  • Morbidity

Diagnostic groups based on ICD10
 

  • C + D Neoplasms

C + D Neoplasms
 

  • Malignant neoplasms gastro intes. system including liver, gall bladder, pancreas
  • Malignant neoplasm lung

6. Other Information
 

  • Alcohol
  • Demographics
  • Smoking

Possibility for linkage to data registries/data enrichment via data linkage
 

  • Cancer incidence
  • Mortality register